English | 简体中文 | 繁體中文 | 한국어
 English Press Releases
 Medicine BioTech
Nanobiotix Announces First Positive Human Data Showing That NBTXR3 Could Become a Backbone in Immuno-Oncology
May 18, 2017 14:00 HKT
Microbiome leader Prof. Borody at China FMT Conference calls for Investment in Faecal Transplant Clinical Trials to Fight Serious Diseases
May 16, 2017 08:00 HKT
Nanobiotix: 2016 Annual Results
Apr 29, 2017 01:00 HKT
Nanobiotix Expands Its Clinical Development in Head and Neck Cancer and Immuno-Oncology
Apr 04, 2017 14:50 HKT
Frost & Sullivan independent industry report identifies PromarkerD as the world leading test for Diabetic Kidney Disease
Mar 28, 2017 18:00 HKT
Frost & Sullivan independent industry report identifies PromarkerD as the world leading test for Diabetic Kidney Disease
Mar 27, 2017 16:00 HKT
NANOBIOTIX: The Independent Data Monitoring Committee Recommends the Continuation of the Ongoing Phase II/III Trial of NBTXR3 in Soft Tissue Sarcoma
Mar 24, 2017 07:00 HKT
Lee's Pharm Announces 2016 Annual Results
Mar 23, 2017 17:54 HKT
PromarkerD Predictive Diagnostics for DKD to Roll-out in Asia
Mar 22, 2017 15:00 HKT
Shanghai Pharmaceuticals Releases 2016 Annual Results
Mar 21, 2017 23:50 HKT
Jacobson Pharma Announces Acquisition of 70% Interest in Hong Ning Hong
Mar 13, 2017 22:19 HKT
Nanobiotix to Present Preclinical Data on Nanoparticle Radioenhancer NBTXR3 at the AACR Annual Meeting 2017
Mar 07, 2017 15:50 HKT
Imprinting Technology Improves Transistor-Based Biosensors
Feb 28, 2017 18:45 HKT
Uni-Bio Science's Drugs Officially Reimbursed under the National Reimbursement Drug List
Feb 27, 2017 09:10 HKT
Improving DNA-Detecting Transistors
Feb 24, 2017 20:30 HKT
Nanobiotix Appoints Senior Executive from Pharmaceutical Industry, as Chief Operating Officer
Feb 07, 2017 16:30 HKT
NANOBIOTIX: 2016 Review and 2017 Anticipated Milestones
Feb 01, 2017 08:00 HKT
Sino Harbour Establishes New Subsidiary; Proposes to Tap Stem Cell Sector in Guangxi, the PRC
Jan 20, 2017 17:45 HKT
Jacobson Pharma to Acquire Saplingtan, Shiling Oil & Col-gan Tablet; Creating an Expandable Proprietary Medicine Platform
Jan 18, 2017 19:44 HKT
Tongfang Kontafarma Announces Proposed Acquisition of 29% Stake in Korean Pharmaceutical Company Binex
Dec 16, 2016 17:24 HKT
<< Previous  Next >>
Copyright © 2026 ACN Newswire - Asia Corporate News Network
Home | About us | Services | Partners | Events | Login | Contact us | Privacy Policy | Terms of Use | RSS
US: +1 214 890 4418 | Beijing: +86 400 879 3881 | Hong Kong: +852 8192 4922 | Singapore: +65 6549 7068 | Tokyo: +81 3 6859 8575

Connect With us: